Evaluating futility of a binary clinical endpoint using early read‐outs
暂无分享,去创建一个
Stijn Vansteelandt | Kelly Van Lancker | An Vandebosch | S. Vansteelandt | F. De Ridder | Filip De Ridder | A. Vandebosch | Kelly Van Lancker
[1] Franz König,et al. Interim analysis incorporating short‐ and long‐term binary endpoints , 2019, Biometrical journal. Biometrische Zeitschrift.
[2] T Friede,et al. Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: An application in multiple sclerosis , 2011, Statistics in medicine.
[3] Steven Snapinn,et al. Assessment of futility in clinical trials , 2006, Pharmaceutical statistics.
[4] Michael R. Chernick,et al. Statistical Monitoring of Clinical Trials: a Unified Approach , 2007, Technometrics.
[5] Meinhard Kieser,et al. Two-stage phase II oncology designs using short-term endpoints for early stopping , 2017, Statistical methods in medical research.
[6] Alan Agresti,et al. Simple and Effective Confidence Intervals for Proportions and Differences of Proportions Result from Adding Two Successes and Two Failures , 2000 .
[7] Meinhard Kieser,et al. Including long- and short-term data in blinded sample size recalculation for binary endpoints , 2005, Comput. Stat. Data Anal..
[8] David J. Spiegelhalter,et al. Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.
[9] K. K. Lan,et al. Stochastically curtailed tests in long–term clinical trials , 1982 .
[10] R. Gray,et al. A general inefficacy interim monitoring rule for randomized clinical trials , 2010, Clinical trials.
[11] Eduardo Gotuzzo,et al. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. , 2014, The New England journal of medicine.
[12] D L DeMets,et al. An aid to data monitoring in long-term clinical trials. , 1982, Controlled clinical trials.
[13] Lisa V. Hampson,et al. Group sequential tests for delayed responses (with discussion) , 2013 .
[14] John Whitehead,et al. Incorporating intermediate binary responses into interim analyses of clinical trials: a comparison of four methods. , 2008, Statistics in medicine.
[15] Tim Friede,et al. A Comparison of Methods for Treatment Selection in Seamless Phase II/III Clinical Trials Incorporating Information on Short-Term Endpoints , 2015, Journal of biopharmaceutical statistics.
[16] Ian C Marschner,et al. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. , 2003, Statistics in medicine.
[17] A. Berger. FUNDAMENTALS OF BIOSTATISTICS , 1969 .
[18] John Whitehead,et al. The sequential analysis of repeated binary responses: a score test for the case of three time points , 2006, Statistics in medicine.
[19] Somesh Chattopadhyay,et al. Statistical Monitoring of Clinical Trials: A Unified Approach , 2008 .
[20] D. Spiegelhalter,et al. Monitoring clinical trials: conditional or predictive power? , 1986, Controlled clinical trials.
[21] D. DeMets,et al. Futility approaches to interim monitoring by data monitoring committees , 2006, Clinical trials.
[22] Tim Friede,et al. Flexible selection of a single treatment incorporating short‐term endpoint information in a phase II/III clinical trial , 2015, Statistics in medicine.
[23] Nigel Stallard,et al. A confirmatory seamless phase II/III clinical trial design incorporating short‐term endpoint information , 2010, Statistics in medicine.
[24] M. Kieser,et al. Choice of futility boundaries for group sequential designs with two endpoints , 2017, BMC Medical Research Methodology.
[25] J. Lachin. A review of methods for futility stopping based on conditional power , 2005, Statistics in medicine.
[26] Meinhard Kieser,et al. An expected power approach for the assessment of composite endpoints and their components , 2013, Comput. Stat. Data Anal..
[27] I. Marschner,et al. Interim monitoring of clinical trials based on long-term binary endpoints. , 2001, Statistics in medicine.
[28] K K Lan,et al. The B-value: a tool for monitoring data. , 1988, Biometrics.
[29] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.